INFINITY PHARMACEUTICALS INC (INFI)       0.55  0 (0%)

0.55  0 (0%)

US45665G3039 - Common Stock

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.12 -0.06 -0.06-96.08% Q2 2022 -0.13 -0.15 0.0212.70% Q1 2022 -0.14 -0.14 0.00-1.67% Q4 2021 -0.13 -0.14 0.015.59% Q3 2021 -0.12 -0.14 0.0212.53% Q2 2021 -0.13 -0.14 0.016.29% Q1 2021 -0.15 -0.13 -0.02-17.81% Q4 2020 -0.16 -0.16 0.00-0.12%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.46 -0.53 13.40%Q4 2022 -0.12 -0.13 5.85%FY 2023 -0.50 -0.46 -8.89%Q1 2023 -0.16 -0.14 -16.57%Q2 2023 -0.18 -0.13 -41.23%Q3 2023 -0.19 -0.12 -61.50%Q4 2023 -0.20 -0.12 -66.67%FY 2024 -0.42 -0.50 16.33%FY 2025 -0.43 -0.42 -1.69%FY 2026 -0.44 -0.43 -3.72%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 712K 6.312M -5.6M-88.72% Q2 2022 686K 528.36K 157.64K29.84% Q1 2022 652K 352.073K 299.927K85.19% Q4 2021 451K 307.53K 143.47K46.65% Q3 2021 428K 534.143K -106.143K-19.87% Q2 2021 512K 284.917K 227.083K79.70% Q1 2021 500K 1.171M -671K-57.30% Q4 2020 400K 281.347K 118.653K42.17%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 2.555M 1.858M 37.51%Q4 2022 455.43K 451K 0.98%FY 2023 1.981M 2.555M -22.47%Q1 2023 714K 652K 9.51%Q2 2023 765K 686K 11.52%Q3 2023 765K 712K 7.44%Q4 2023 816K 455.43K 79.17%FY 2024 1.64M 1.981M -17.21%FY 2025 1.289M 1.64M -21.38%FY 2026 1.034M 1.289M -19.83%